Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ALGSALGS

8 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ALIGOS THERAPEUTICS INC

Yes. BNP Paribas Financial Markets holds 3 shares of ALGS (Aligos Therapeutics), worth $17, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. BNP Paribas Financial Markets has held ALGS since Q3 2024, across 8 quarterly 13F filings.

Current Value

$17

Current Shares

3

Total Value Change

-$9

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
3
0.0%
$170.0%$5.77
0
2026-Q1
Unchanged
3
0.0%
$220.0%$6.85
0
2025-Q4
Unchanged
3
0.0%
$280.0%$9.12
0
2025-Q3
Decreased
3
-99.8%
$290.0%$9.62
0
2025-Q2
Increased
1,816
+604x
$13,0930.0%$7.21
19
2025-Q1
Unchanged
3
0.0%
$250.0%$9.12
0
2024-Q4
Unchanged
3
0.0%
$1200.0%$40.47
0
2024-Q3
New
3
—
$260.0%$8.04
17

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used